Ad hoc Announcement according to Art. 17 Market Abuse Regulation
QIAGEN to conduct an up to $200 million share repurchase program Venlo, The Netherlands, January 31, 2018 – QIAGEN N.V. announces that its Managing Board, upon authorization of the Supervisory Board, has passed a resolution to exercise the authorization granted by the General Meeting of Shareholders on June 21, 2017, and to purchase shares in the... Read more